A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

NCT01181102 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

716

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: edoxaban
DRUG: enoxaparin sodium

Sponsor

Daiichi Sankyo Co., Ltd.